Adherence to long‐term anticoagulation treatment, what is known and what the future might hold

Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2016-07, Vol.174 (1), p.30-42
Hauptverfasser: Abdou, John K., Auyeung, Vivian, Patel, Jignesh P., Arya, Roopen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue 1
container_start_page 30
container_title British journal of haematology
container_volume 174
creator Abdou, John K.
Auyeung, Vivian
Patel, Jignesh P.
Arya, Roopen
description Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.
doi_str_mv 10.1111/bjh.14134
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808639175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1799205231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</originalsourceid><addsrcrecordid>eNqFkE1OwzAQRi0EoqWw4ALIS5BIa9d2fpalAgqqxKb74DqTJiWJi-2o6o4jcEZOgiGFHWI2oxk9faN5CJ1TMqS-Rst1MaScMn6A-pSFIhj76RD1CSFRQAmPe-jE2jUhlBFBj1FvHNGIRTzso-dJVoCBRgF2Gle6WX28vTswNZaNK5WWq7aSrtQNdgakq6Fx13hbSIdLi18avW08mHUbVwDOW9cawHW5KhwudJWdoqNcVhbO9n2AFne3i-ksmD_dP0wn80DxkPEgT3IGIua5imKAjEuluFC5VCyJEilovEyUDEXGFWU5Y5TFVMgQ4lD4T4CwAbrsYjdGv7ZgXVqXVkFVyQZ0a1MakzhkCY3E_2iUJGMixv7IAF11qDLaWgN5ujFlLc0upST9Up969em3es9e7GPbZQ3ZL_nj2gOjDtiWFez-TkpvHmdd5CfWiY5H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1799205231</pqid></control><display><type>article</type><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</creator><creatorcontrib>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</creatorcontrib><description>Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.14134</identifier><identifier>PMID: 27173746</identifier><language>eng</language><publisher>England</publisher><subject>Anticoagulants - therapeutic use ; atrial fibrillation ; direct oral anticoagulants ; Humans ; Long-Term Care ; medication adherence ; Medication Adherence - psychology ; Models, Psychological ; venous thromboembolism ; vitamin K antagonists</subject><ispartof>British journal of haematology, 2016-07, Vol.174 (1), p.30-42</ispartof><rights>2016 John Wiley &amp; Sons Ltd</rights><rights>2016 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</citedby><cites>FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</cites><orcidid>0000-0002-9294-3174</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.14134$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.14134$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27173746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdou, John K.</creatorcontrib><creatorcontrib>Auyeung, Vivian</creatorcontrib><creatorcontrib>Patel, Jignesh P.</creatorcontrib><creatorcontrib>Arya, Roopen</creatorcontrib><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</description><subject>Anticoagulants - therapeutic use</subject><subject>atrial fibrillation</subject><subject>direct oral anticoagulants</subject><subject>Humans</subject><subject>Long-Term Care</subject><subject>medication adherence</subject><subject>Medication Adherence - psychology</subject><subject>Models, Psychological</subject><subject>venous thromboembolism</subject><subject>vitamin K antagonists</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1OwzAQRi0EoqWw4ALIS5BIa9d2fpalAgqqxKb74DqTJiWJi-2o6o4jcEZOgiGFHWI2oxk9faN5CJ1TMqS-Rst1MaScMn6A-pSFIhj76RD1CSFRQAmPe-jE2jUhlBFBj1FvHNGIRTzso-dJVoCBRgF2Gle6WX28vTswNZaNK5WWq7aSrtQNdgakq6Fx13hbSIdLi18avW08mHUbVwDOW9cawHW5KhwudJWdoqNcVhbO9n2AFne3i-ksmD_dP0wn80DxkPEgT3IGIua5imKAjEuluFC5VCyJEilovEyUDEXGFWU5Y5TFVMgQ4lD4T4CwAbrsYjdGv7ZgXVqXVkFVyQZ0a1MakzhkCY3E_2iUJGMixv7IAF11qDLaWgN5ujFlLc0upST9Up969em3es9e7GPbZQ3ZL_nj2gOjDtiWFez-TkpvHmdd5CfWiY5H</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Abdou, John K.</creator><creator>Auyeung, Vivian</creator><creator>Patel, Jignesh P.</creator><creator>Arya, Roopen</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0002-9294-3174</orcidid></search><sort><creationdate>201607</creationdate><title>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</title><author>Abdou, John K. ; Auyeung, Vivian ; Patel, Jignesh P. ; Arya, Roopen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4634-f9f3e584fc78eed4acc45cfac3979a518b9ca65d4c13f3313815a6e865173e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anticoagulants - therapeutic use</topic><topic>atrial fibrillation</topic><topic>direct oral anticoagulants</topic><topic>Humans</topic><topic>Long-Term Care</topic><topic>medication adherence</topic><topic>Medication Adherence - psychology</topic><topic>Models, Psychological</topic><topic>venous thromboembolism</topic><topic>vitamin K antagonists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdou, John K.</creatorcontrib><creatorcontrib>Auyeung, Vivian</creatorcontrib><creatorcontrib>Patel, Jignesh P.</creatorcontrib><creatorcontrib>Arya, Roopen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdou, John K.</au><au>Auyeung, Vivian</au><au>Patel, Jignesh P.</au><au>Arya, Roopen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence to long‐term anticoagulation treatment, what is known and what the future might hold</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2016-07</date><risdate>2016</risdate><volume>174</volume><issue>1</issue><spage>30</spage><epage>42</epage><pages>30-42</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary Adherence to medication, commonly reported as being 50% in chronic diseases, is of great concern in healthcare. Medication non‐adherence is particularly apparent in chronic diseases, where treatment is often preventative and may provide little or no symptomatic relief or feedback for the patient. A lot of research has been undertaken to describe the extent of non‐adherence to long‐term anticoagulation therapy, particularly with vitamin K antagonists and more recently with direct oral anticoagulants. However, the literature is scarce with respect to describing adherence to anticoagulation in terms of the behavioural aspects that influence medicine use. Utilizing the COM‐B (capability, opportunity, motivation and behaviour) psychological model of non‐adherence, we present the available evidence, not only in terms of describing the extent of the non‐adherence problem, but also describing why patients do not adhere, offering theory‐driven and evidence‐based solutions to improve long‐term adherence to chronic anticoagulation therapy. Lessons learned are not only applicable within the field of anticoagulation but throughout haematology.</abstract><cop>England</cop><pmid>27173746</pmid><doi>10.1111/bjh.14134</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-9294-3174</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2016-07, Vol.174 (1), p.30-42
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_1808639175
source Wiley Free Content; MEDLINE; Wiley Online Library All Journals
subjects Anticoagulants - therapeutic use
atrial fibrillation
direct oral anticoagulants
Humans
Long-Term Care
medication adherence
Medication Adherence - psychology
Models, Psychological
venous thromboembolism
vitamin K antagonists
title Adherence to long‐term anticoagulation treatment, what is known and what the future might hold
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T17%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20to%20long%E2%80%90term%20anticoagulation%20treatment,%20what%20is%20known%20and%20what%20the%20future%20might%20hold&rft.jtitle=British%20journal%20of%20haematology&rft.au=Abdou,%20John%20K.&rft.date=2016-07&rft.volume=174&rft.issue=1&rft.spage=30&rft.epage=42&rft.pages=30-42&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.14134&rft_dat=%3Cproquest_cross%3E1799205231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1799205231&rft_id=info:pmid/27173746&rfr_iscdi=true